Navigation Links
Novexel to be Acquired by AstraZeneca
Date:12/23/2009

PARIS, December 23 /PRNewswire/ -- Novexel, a speciality pharmaceutical company focused on the discovery and development of novel antibiotics designed to overcome the significant global problem of microbial drug resistance, announces today that its shareholders have signed a definitive agreement whereby Novexel shall be acquired by AstraZeneca for a total cash consideration of up to $505 million, including contingent payments and the net cash position of the company at closing. The transaction is expected to close in the first quarter of 2010, subject to certain customary conditions, including the expiration or termination of the applicable waiting period under the Hart-Scott-Rodino Antitrust Improvement Act of 1976.

Under the terms of the agreement, AstraZeneca will acquire 100 percent of Novexel's shares for $350 million in cash payable upon completion and will pay up to an additional $75 million to Novexel shareholders if specified development milestones are reached. AstraZeneca will also transfer to Novexel shareholders an amount equivalent to the cash balance of Novexel at closing. The cash balance of Novexel at closing is expected to be approximately $80 million. This transaction will provide AstraZeneca with an attractive portfolio of clinical and preclinical compounds which are designed to address infections caused by drug-resistant bacteria in the hospital.

    Novexel's clinical development pipeline includes:

    - NXL104, a novel beta-lactamase inhibitor. NXL104 in
      combination with the cephalosporin antibiotic ceftazidime (CAZ-104) is
      currently in two Phase II clinical trials in patients with complicated
      intra-abdominal infections (cIAIs) and patients with complicated
      urinary tract infections (cUTIs). Under an agreement concluded in
      January 2008, Novexel granted Forest Laboratories the rights to develop
      NXL104 in combination with ceftaroline (CEF-104) in North Ame
'/>"/>
SOURCE Novexel
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Novexel Reports Positive Phase II Trial Results With NXL103 in Adult Patients With Community Acquired Pneumonia
2. Novexel to Present Five Posters at the Joint Annual Interscience Conference on Antimicrobial Agents and Chemotherapy and the Infectious Disease Society of America (ICAAC/IDSA) Meeting
3. Novexels NXL104/ceftazidime Combination Commences Phase II Clinical Trial in Hospital Patients With Complicated Urinary Tract Infections
4. Novexels NXL104/ceftazidime Combination Commences Second Phase II Clinical Trial in Hospital Patients With Complicated Intra-Abdominal Infections (cIAIs)
5. Novexel to Present Four Posters at the 19th European Congress of Clinical Microbiology and Infectious Diseases in Helsinki
6. Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI)
7. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
8. New Data Show Doripenem as Effective as Commonly Used Therapies in Treating Hospital-Acquired Pneumonias
9. FDA Accepts Wyeths Supplemental New Drug Application for Tygacil for the Treatment of Patients with Community-Acquired Pneumonia
10. Enanta Reports New Macrolide-Related Drug Class, Bicyclolides, to Combat Hospital and Community Acquired Superbug Infections, Including MRSA
11. Wyeth Receives Approvable Letter from FDA for TYGACIL for the Treatment of Patients with Community-Acquired Pneumonia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/1/2015)... May 1, 2015   Heska Corporation (NASDAQ: ... a provider of advanced veterinary diagnostic and other specialty ... Executive Chair, will present at the 16th Annual B. Riley ... 13, 2015. The conference will be held May 12-14, 2015 ... Heska management will be available during the day on ...
(Date:5/1/2015)... , May 1, 2015 At the ... 2-6 in Washington D.C. , Elekta ... solution that enables clinicians to leverage the enormous amount ... radiosurgery treatments conducted each year – to advance clinical ... Knife Registry is a cloud-based solution that allows practitioners ...
(Date:5/1/2015)... , May 1, 2015 Braeburn ... its current therapeutic focus beyond addiction and ... psychiatric disorders. Braeburn has acquired an implantable, ... antipsychotic risperidone for treatment of schizophrenia from ... acquires global rights to other potential applications ...
Breaking Medicine Technology:Heska to Present at the 16th Annual B. Riley & Co. Investor Conference 2Elekta to showcase Leksell Gamma Knife Registry at AANS Annual Meeting 2Elekta to showcase Leksell Gamma Knife Registry at AANS Annual Meeting 3Braeburn Pharmaceuticals expands pipeline to include two schizophrenia treatments 2Braeburn Pharmaceuticals expands pipeline to include two schizophrenia treatments 3Braeburn Pharmaceuticals expands pipeline to include two schizophrenia treatments 4
... 2011 New brand established for group ... New name of group of companies is ,Sanavis Group, ... separate entities under the Sanavis umbrella Dr. Martin Rickert ... form one of the ten largest dental equipment manufacturers worldwide ...
... 4, 2011 Misonix, Inc. (Nasdaq: ... manufactures, and markets innovative therapeutic ultrasonic products worldwide ... and other surgical and medical applications, today announced ... 2010 financial results on Wednesday, February 9, 2011. ...
Cached Medicine Technology:SciCan Post Merger Group Branding Revealed 2SciCan Post Merger Group Branding Revealed 3Misonix Schedules Second Quarter 2011 Financial Results Conference Call; February 9, 2011 at 4:30 p.m. Eastern 2
(Date:5/1/2015)... KY (PRWEB) May 01, 2015 Ernst ... CEO, Dr. Joshua Rosenthal, Co-Founder & CSO, and Burak ... finalists for the EY Entrepreneur Of The Year® ... Ernst & Young is a global leader in ... to be one of the top audit companies ...
(Date:5/1/2015)... Florida (PRWEB) May 01, 2015 The Quail ... the American Cancer Society. Since 2001, the Quail Creek Relay ... Relay team host events throughout the year, including their biggest ... the Golf Ball Drop. , Quail Creek Relay for ... was battling cancer. Kate Kerwin, fitness director, states, “I was ...
(Date:5/1/2015)... Colorado (PRWEB) May 01, 2015 As ... States approaches its 18-month anniversary, many people in the ... been achieved. , According the latest annual report by ... expanded 74 percent in 2014, and reached nearly $3 ... America’s decades-long love affair with cannabis, combined with the ...
(Date:5/1/2015)... The frozen yogurt chain sweetFrog Enterprises is ... and the Myrtle Beach Pellicans (SC). As part of ... offer fans discounts at local sweetFrog locations. , “We ... Luke Shook, co-owner of the Hickory sweetFrog. “Sponsoring ... forward to enjoying the games and the great taste ...
(Date:5/1/2015)... Veteran Outreach Pittsburgh - Events , The Mobile Vet ... Centers on May 6, starting at 5 p.m., in Pittsburgh’s ... of the SouthSide Works Theater, 425 Cinema Drive, Pittsburgh, PA ... “That Which I Love Destroys Me,” and a panel discussion ... Robert Novotney for more information on the VA Vet Centers ...
Breaking Medicine News(10 mins):Health News:RowdMap, Inc. Named as a Ernst & Young Entrepreneur Of The Year® 2015 Award Finalist 2Health News:Quail Creek Country Club’s Relay for Life Team Raised Over $89,000 for American Cancer Society 2Health News:Colorado cannabis dispensary owner credits employees for successful “420” retail sales figures 2Health News:Colorado cannabis dispensary owner credits employees for successful “420” retail sales figures 3Health News:sweetFrog Announces Minor League Baseball Partnerships 2
... ... a 250km (155 miles) race across the Sahara desert this April 2010. Gary is doing this ... ... Sables will cover 250km/155 miles (in sections approximate to 25, 34, 38, 82, 42, 22 km) ...
... USA Today, during the 39th Annual Meeting ... at the Walter E. Washington Convention Center in ... Kentucky, Lexington) will present a poster of a ... Pathogens induce HIV-1 Reactivation." Although oral co-infections (e.g. ...
... ... the safety of the company,s products are taken very seriously. , , ... Bloomingdale, IL (PRWEB) March 4, 2010 -- ... to lead healthier lives. Product safety and quality are the company,s highest priorities; therefore any ...
... , ... ... ... ...
... in dirty air and heart problems , THURSDAY, March ... pollution particles caused by traffic has been linked to ... In the new report, researchers analyzed data from 939 ... every four years between 1995 and 2006. A computer ...
... ... anyone should continue driving them before having them fixed. , ... New York (PRWEB) March 4, 2010 -- In one of the latest incidents ... Jerry Silver, 86, lost control of his car and collided with two parked vehicles before coming ...
Cached Medicine News:Health News:Mt. Everest Summiter Gary Guller (With One Arm) To Race Across Sahara in "The World's Toughest Stage Race" 2Health News:Mt. Everest Summiter Gary Guller (With One Arm) To Race Across Sahara in "The World's Toughest Stage Race" 3Health News:Periodontal pathogens enhance HIV-1 promoter activation in T cells 2Health News:NOW Foods Response to Fish Oil and PCB Concerns 2Health News:SarahCare(R) and Posit Science Corporation(R) Join Forces to Bring Brain Fitness to Seniors at SarahCare(R) of Minnesota 2Health News:SarahCare(R) and Posit Science Corporation(R) Join Forces to Bring Brain Fitness to Seniors at SarahCare(R) of Minnesota 3Health News:SarahCare(R) and Posit Science Corporation(R) Join Forces to Bring Brain Fitness to Seniors at SarahCare(R) of Minnesota 4Health News:SarahCare(R) and Posit Science Corporation(R) Join Forces to Bring Brain Fitness to Seniors at SarahCare(R) of Minnesota 5Health News:Years of Exposure to Traffic Pollution Raises Blood Pressure 2Health News:New York Personal Injury Lawyers Concerned About Toyota Accident in Queens 2Health News:New York Personal Injury Lawyers Concerned About Toyota Accident in Queens 3
... TOX/See™ is a 1-step, hand-held, point-of-care device for ... in human urine. The TOX/See device can ... abused drugs in 3 to 8 minutes and ... TOX/See cassette is individually packaged to maximize convenience ...
... is an NIST-traceable thermometer that measures temperatures ... convenience of an easy-to-read display and minimum/maximum ... is mounted magnetically, with adhesive, by keyhole ... no calibration and is accurate to within ...
Streck Cytometry Sheath fluid is a ready-to-use, balanced isotonic solution for use on flow cytometers. It is packaged in a 20 liter Cubitainer, and offers a two-year shelf life....
Streck-T-Pack is specially designed for use on Coulter® Counter T Series instruments. Each convenient pack includes diluent, lysing agent and enzymatic cleanser. The shelf life is 18 months from ...
Medicine Products: